Synchrony Financial experienced lower loan growth in preparation for a rule limiting late fees. Nevertheless, core 2025 EPS ...

Good morning, and welcome to the Synchrony Financial fourth quarter and full year 2024 earnings conference call. Please refer ...

Synchrony Financial said on Tuesday it expects lower net revenue for 2025 as spending levels moderate and interest rates dip, ...

NEW YORK, NY / ACCESS Newswire / February 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Synchrony ...

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the ...

Q4 2024 Earnings Call Transcript January 28, 2025 Synchrony Financial misses on earnings expectations. Reported EPS is $1.91 ...

Synchrony Financial (NYSE: NYSE:SYF), a leading consumer financial services company, has demonstrated remarkable resilience in the face of regulatory challenges and economic uncertainties. As of ...

Synchrony Financial reported Q4 results with a Y/Y increase in net interest income, driven by higher interest and fees on ...

Synchrony Financial's fourth-quarter earnings results missed analysts' forecasts and investors pummeled the stock due to a ...

BTIG analyst Vincent Caintic has maintained their neutral stance on SYF stock, giving a Hold rating yesterday.Invest with Confidence: Follow ...

Brian Wenzel; Chief Financial Officer, Executive Vice President; Synchrony Financial Good morning and welcome to the Synchrony Financial fourth-quarter and full year 2024 earnings conference call.

Synchrony Financial partners with retailers and medical providers to offer promotional financing as well as private-label and co-branded general-purpose credit cards. While the company’s CareCredit ...